New Zealand markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.09-1.09 (-17.64%)
At close: 04:00PM EST
5.11 +0.02 (+0.39%)
After hours: 07:54PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts106109
Avg. Estimate-0.84-0.52-3.62-2.44
Low estimate-0.96-0.76-3.75-3.58
High estimate-0.72-0.14-3.51-1.91
Year ago EPS-1.77-0.93-9.31-3.62
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts941010
Avg. Estimate21.07M23.15M77.73M164.62M
Low estimate18.1M22.4M75.1M91.3M
High estimate27.3M24.7M83.96M346M
Year ago sales15.4M18.84M78.45M77.73M
Sales growth (year/est)36.80%22.90%-0.90%111.80%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-2.27-1.04-0.93-0.92
Actual EPS-1.77-0.93-1.05-0.81
Difference0.50.11-0.120.11
Surprise %22.00%10.60%-12.90%12.00%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.84-0.52-3.62-2.44
7 days ago-0.84-0.52-3.62-2.44
30 days ago-0.84-0.52-3.62-2.44
60 days ago-0.88-0.63-3.8-2.26
90 days ago-0.88-0.69-3.8-2.28
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.52.50%N/AN/AN/A
Next qtr.44.10%N/AN/AN/A
Current year61.10%N/AN/AN/A
Next year32.60%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A